Physician profile
Mark Borenstein
NPI 1205891140
$3,294.60
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $558 · 2021: $1,498 · 2022: $442 · 2023: $68.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,072.70 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $1,012.13 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $607.80 | 2019-2022 | |
| Cardiovascular Systems INC. | $335.96 | 2019-2022 | |
| Abbott Laboratories | $88.42 | 2019-2021 | |
| Cordis US Corp. | $68.29 | 2023 | |
| Avenu Medical INC. | $43.11 | 2020 | |
| Angiodynamics, INC. | $28.18 | 2022 | |
| Vasorum USA INC. | $23.49 | 2022 | |
| Axonics, INC. | $14.52 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Borenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.